Origin Materials Statistics
Total Valuation
ORGN has a market cap or net worth of $64.48 million. The enterprise value is -$11.01 million.
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025, after market close.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ORGN has 149.94 million shares outstanding. The number of shares has increased by 1.37% in one year.
| Current Share Class | 149.94M |
| Shares Outstanding | 149.94M |
| Shares Change (YoY) | +1.37% |
| Shares Change (QoQ) | +1.94% |
| Owned by Insiders (%) | 3.59% |
| Owned by Institutions (%) | 15.11% |
| Float | 131.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.08 |
| Forward PS | 0.72 |
| PB Ratio | 0.20 |
| P/TBV Ratio | 0.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.51, with a Debt / Equity ratio of 0.02.
| Current Ratio | 9.51 |
| Quick Ratio | 8.37 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -223.95 |
Financial Efficiency
Return on equity (ROE) is -26.63% and return on invested capital (ROIC) is -11.37%.
| Return on Equity (ROE) | -26.63% |
| Return on Assets (ROA) | -10.60% |
| Return on Invested Capital (ROIC) | -11.37% |
| Return on Capital Employed (ROCE) | -20.10% |
| Revenue Per Employee | $274,193 |
| Profits Per Employee | -$882,798 |
| Employee Count | 109 |
| Asset Turnover | 0.07 |
| Inventory Turnover | 33.12 |
Taxes
In the past 12 months, ORGN has paid $610,000 in taxes.
| Income Tax | 610,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -52.22% in the last 52 weeks. The beta is 0.81, so ORGN's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | -52.22% |
| 50-Day Moving Average | 0.57 |
| 200-Day Moving Average | 0.99 |
| Relative Strength Index (RSI) | 38.34 |
| Average Volume (20 Days) | 801,659 |
Short Selling Information
The latest short interest is 3.38 million, so 2.25% of the outstanding shares have been sold short.
| Short Interest | 3.38M |
| Short Previous Month | 3.49M |
| Short % of Shares Out | 2.25% |
| Short % of Float | 2.56% |
| Short Ratio (days to cover) | 2.13 |
Income Statement
In the last 12 months, ORGN had revenue of $29.89 million and -$96.23 million in losses. Loss per share was -$0.67.
| Revenue | 29.89M |
| Gross Profit | 393,000 |
| Operating Income | -67.63M |
| Pretax Income | -853,000 |
| Net Income | -96.23M |
| EBITDA | -56.52M |
| EBIT | -67.63M |
| Loss Per Share | -$0.67 |
Full Income StatementBalance Sheet
The company has $83.05 million in cash and $7.56 million in debt, giving a net cash position of $75.48 million or $0.50 per share.
| Cash & Cash Equivalents | 83.05M |
| Total Debt | 7.56M |
| Net Cash | 75.48M |
| Net Cash Per Share | $0.50 |
| Equity (Book Value) | 314.61M |
| Book Value Per Share | 2.10 |
| Working Capital | 106.94M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$42.53 million and capital expenditures -$14.01 million, giving a free cash flow of -$56.54 million.
| Operating Cash Flow | -42.53M |
| Capital Expenditures | -14.01M |
| Free Cash Flow | -56.54M |
| FCF Per Share | -$0.38 |
Full Cash Flow StatementMargins
| Gross Margin | 1.31% |
| Operating Margin | -226.30% |
| Pretax Margin | -319.92% |
| Profit Margin | n/a |
| EBITDA Margin | -189.10% |
| EBIT Margin | -226.30% |
| FCF Margin | n/a |
Dividends & Yields
ORGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.37% |
| Shareholder Yield | -1.37% |
| Earnings Yield | -149.24% |
| FCF Yield | -87.69% |
Analyst Forecast
The average price target for ORGN is $3.00, which is 597.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.00 |
| Price Target Difference | 597.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ORGN has an Altman Z-Score of 2.24 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.24 |
| Piotroski F-Score | 3 |
